Skip to main content

Advertisement

SpringerLink
Log in

Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Ovarian granulosa cell tumors (GCTs) typically exhibit an excellent prognosis, but their recurrences are associated with high mortality rates. In the past, immunohistochemistry (IHC)-based approaches have been used to facilitate the distinction between GCTs and other, more frequently occurring, primary or metastatic tumors. The purpose of this study was to assess the added value of H1.5 and PLZF protein expression in the correct delineation of GCTs.

Methods

Consecutive 5-μm thick sections from routinely fixed and paraffin embedded tissues from 30 GCTs and 33 benign ovaries were processed for IHC using anti-PLZF and anti-H1.5 monoclonal antibodies. The respective protein staining intensities and distributions were quantified into reported scores for all tissue samples. Student’s t-test and Fisher’s exact test were used to compare the mean scores for each group. A p-value of <0.05 was considered statistically significant. Also, both the sensitivity and the specificity of the two antibodies were evaluated.

Results

A statistically significant difference in the expression of H1.5 between the GCT and normal ovary groups was observed (p < 0.0001). Normal ovarian tissues were found to strongly express H1.5, whereas GCTs were found to weakly express this protein. In contrast, PLZ expression was not found to be significantly different between both study groups.

Conclusions

From our results we conclude that H1.5 is down-regulated in GCTs compared to normal ovarian tissues. Additional investigations on larger and more heterogeneous study populations, and on the molecular mechanism (s) underlying down-regulation of the H1.5 protein, may further substantiate the use of H1.5 as a diagnostic/prognostic marker and, in addition, provide insight into the pathogenesis of GCTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. S.T. Schumer, S.A. Cannistra, Granulosa cell tumor of the ovary. J. Clin. Oncol. 21, 1180–1189 (2003)

    Article  PubMed  Google Scholar 

  2. L. Unkila-Kallio, A. Tiitinen, T. Wahlstrom, P. Lehtovirta, A. Leminen, Reproductive features in women developing ovarian granulosa cell tumour at a fertile age. Hum. Reprod. 15(3), 589–593 (2000)

    Article  CAS  PubMed  Google Scholar 

  3. D. Pectasides, E. Pectasides, A. Psyrri, Granulosa cell tumor of the ovary. Cancer Treat. Rev. 34, 1–12 (2008)

    Article  CAS  PubMed  Google Scholar 

  4. L. Merras-Salmio, K. Vettenranta, M. Mottonen, M. Heikinheimo, Ovarian granulosa cell tumors in childhood. Pediatr. Hematol. Oncol. 19, 145–156 (2002)

    Article  PubMed  Google Scholar 

  5. T. Fujimoto, N. Sakuragi, K. Okuyama, T. Fujino, K. Yamashita, S. Yamashiro, M. Shimizu, S. Fujimoto, Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet. Gynecol. Scand. 80, 1069–1074 (2001)

    Article  CAS  PubMed  Google Scholar 

  6. H.S. Cronje, I. Niemand, R.H. Bam, J.D. Woodruff, Review of the granulosa-theca cell tumors from the Emil Novak ovarian tumor registry. Am. J. Obstet. Gynecol. 180, 323–327 (1999)

    Article  CAS  PubMed  Google Scholar 

  7. R.H. Young, R.E. Scully, Ovarian sex cord-stromal tumors. Problems in differential diagnosis. Pathol. Annu. 23, 237–296 (1988)

    PubMed  Google Scholar 

  8. S. Nofech-Mozes, N. Ismiil, V. Dubé, R.S. Saad, M.A. Khalifa, O. Moshkin, Z. Ghorab, Immunohistochemical characterization of primary and recurrent adult granulosa cell tumors. Int. J. Gynecol. Pathol. 31(1), 80–90 (2012)

    Article  CAS  PubMed  Google Scholar 

  9. P.L. Yeyati, R. Shaknovich, S. Boterashvili, J. Li, H.J. Ball, S. Waxman, K. Nason-Burchenal, E. Dmitrovsky, A. Zelent, J.D. Licht, Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18(4), 925–934 (1999)

    Article  CAS  PubMed  Google Scholar 

  10. F. Felicetti, L. Bottero, N. Felli, G. Mattia, C. Labbaye, E. Alvino, C. Peschle, M.P. Colombo, A. Carè, Role of PLZF in melanoma progression. Oncogene 23(26), 4567–4576 (2004)

    Article  CAS  PubMed  Google Scholar 

  11. M. Cheung, J. Pei, Y. Pei, S.C. Jhanwar, H.I. Pass, J.R. Testa, The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene 29(11), 1633–1640 (2010). doi:10.1038/onc.2009.455. Epub 2009 Dec 14

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. D.A. Hill, Influence of linker histone H1 on chromatin remodeling. Biochem. Cell Biol. 79(3), 317–324 (2001)

    Article  CAS  PubMed  Google Scholar 

  13. N. Happel, S. Stoldt, B. Schmidt, D. Doenecke, M phase-specific phosphorylation of histone H1.5 at threonine 10 by GSK-3. J. Mol. Biol. 386(2), 339–350 (2009)

    Article  CAS  PubMed  Google Scholar 

  14. Sato S, Takahashi S, Asamoto M, Nakanishi M, Wakita T, Ogura Y, Yatabe Y, Shirai T. Histone H1 expression in human prostate cancer tissues and cell lines. Pathol Int. 2012 Feb;62(2):84–92. doi: 10.1111/j.1440-1827.2011.02755.x. Epub 2011 Nov 28.

  15. J.F. Hechtman, M.B. Beasley, Y. Kinoshita, H.M. Ko, K. Hao, D.E. Burstein, Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study. Hum. Pathol. 44, 1400–1405 (2013)

    Article  CAS  PubMed  Google Scholar 

  16. M. Markman, M.E. Randall, R.R. Barakat, Principles and practice of gynecologic oncology (Lippencott Williams & Wilkins, Philadelphia, 2009)

    Google Scholar 

  17. R.H. Young, G.R. Dickersin, R.E. Scully, Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am. J. Surg. Pathol. 8(8), 575–596 (1984)

    Article  CAS  PubMed  Google Scholar 

  18. R.H. Young, Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod. Pathol. 18, S81–S98 (2005)

    Article  PubMed  Google Scholar 

  19. W.G. McCluggage, Immunoreactivity of ovarian juvenile granulosa cell tumours with epithelial membrane antigen. Histopathology 46, 235–236 (2005)

    Article  CAS  PubMed  Google Scholar 

  20. A.C. Assis Neto, B.A. Ball, P. Browne, A.J. Conley, Cellular localization of androgen synthesis in equine granulosa-theca cell tumors: Immunohistochemical expression of 17α-hydroxylase/17,20-lyase cytochrome P450. Theriogenology 74, 393–401 (2010)

    Article  CAS  Google Scholar 

  21. K.T. Loo, A.K.F. Leung, J.K.C. Chan, Immunohistochemical staining of ovarian granulosa cell tumours with MIC2 antibody. Histopathology 27, 388–390 (1995)

    Article  CAS  PubMed  Google Scholar 

  22. C. Zhao, T.N. Vinh, K.Q.I.H.C. McManus, D. Dabbs, R. Barner, R. Vang, Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am. J. Surg. Pathol. 33, 354–366 (2009)

    Article  PubMed  Google Scholar 

  23. B.A. Ball, A.J. Conley, D.T. MacLaughlin, S.A. Grundy, K. Sabeur, I.K.M. Liu, Expression of anti-mullerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries. Theriogenology 70, 968–977 (2008)

    Article  CAS  PubMed  Google Scholar 

  24. C. Barcena, E. Oliva, WT1 expression in the female genital tract. Advanced Anatomic Patholology 18(6), 454–465 (2011)

    Article  CAS  Google Scholar 

  25. A. Farkkila, M. Anttonen, J. Pociuviene, A. Leminen, R. Butzow, M. Heikinheimo, L. Unkila-Kallio, Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors. Eur. J. Endocrinol. 164, 115–122 (2011)

    Article  CAS  PubMed  Google Scholar 

  26. Y. Ohishi, T. Kaku, M. Oya, H. Kobayashi, N. Wake, M. Tsuneyoshi, CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls. Gynecol. Oncol. 107, 30–38 (2007)

    Article  CAS  PubMed  Google Scholar 

  27. E. Oliva, N. Garcia-Miralles, Q. Vu, R.H. Young, CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Int. J. Gynecol. Pathol. 26, 359–367 (2007)

    Article  PubMed  Google Scholar 

  28. L. Wang, X. Chang, G. Yuan, Y. Zhao, P. Wang, Expression of peptidylarginine deiminase type 4 in ovarian tumors. Int. J. Biol. Sci. 6, 454–464 (2010)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Y. Fan, T. Nikitina, J. Zhao, T.J. Fleury, R. Bhattacharyya, E.E. Bouhassira, A. Stein, C.L. Woodcock, A.I. Skoultchi, Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 123(7), 1199–1212 (2005)

    Article  CAS  PubMed  Google Scholar 

  30. X. Shen, M.A. Gorovsky, Linker histone H1 regulates specific gene expression but not global transcription in vivo. Cell 86(3), 475–483 (1996)

    Article  CAS  PubMed  Google Scholar 

  31. H. Lee, R. Habas, C. Abate-Shen, MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science 304(5677), 1675–1678 (2004)

    Article  CAS  PubMed  Google Scholar 

  32. N.N. Kostova, L.N. Srebreva, A.D. Milev, O.G. Bogdanova, I. Rundquist, H.H. Lindner, D.V. Markov, Immunohistochemical demonstration of histone H1° in human breast carcinoma. Histochem. Cell Biol. 124, 435–443 (2005)

    Article  CAS  PubMed  Google Scholar 

  33. S.J. Chen, A. Zelent, J.H. Tong et al., Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t (11; 17) (q 23; q 21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91, 2260–2267 (1993)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. L. Buluwela, J. Pike, D. Mazhar, T. Kamalati, S.M. Hart, R. Al-Jehani, H. Yahaya, N. Patel, N. Sarwarl, D.A. Heathcote, O. Schwickerath, F. Phoenix, R. Hill, E. Aboagye, S. Shousha, J. Waxman, N.R. Lemoine, A. Zelent, R.C. Coombes, S. Ali, Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF. Gene Ther. 12, 452–460 (2005)

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors report no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Sara Farag, Linus Chuang & David Fishman

  2. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Tamara Kalir & David E. Burstein

  3. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, 1176 Fifth Avenue, 10029-6574, Box 1173, New York, NY, USA

    Mazdak Momeni

Authors
  1. Mazdak Momeni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tamara Kalir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sara Farag
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Linus Chuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David Fishman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David E. Burstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mazdak Momeni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Momeni, M., Kalir, T., Farag, S. et al. Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report. Cell Oncol. 37, 229–234 (2014). https://doi.org/10.1007/s13402-014-0174-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-014-0174-8

Keywords

Search

Navigation